January/February 2015 Volume 7/ Issue 1

<<< contents

■ Reviews of Literature

Kuleshov A.V. Magnesium value at mitral valve prolapse in children. International Journal of Pediatrics, Obstetrics and Gynecology 2015;Vol 7(1):57-67

Magnesium value at mitral valve prolapse in children

Kuleshov A.V.

Pirogovs Vinnitsa National Medical University, Vinnitsa, Ukraine

■ Abstract:

The article describes the basic structure of the connective tissue and its changes at magnesium deficiency. The role of magnesium in the development of mitral valve prolapse was described.

■ Key words:

mitral valve prolapse, magnesium, connective tissue dysplasia

■ References:

1. Avtandilov A.G., Dzeranova K.M., Borovaya T.G., Didenko L.V. Vliyanie orotata magniya na soedinitel'nyy karkas i inotropnuyu funktsyiyu serdtsa u patsientov s prolapsom mitral'nogo klapana. Ratsional'naya Farmakoterapiya v Kardiologii 2013; 9(4): 390-397.

2. Belozerov Yu. M. Osmanov I. M., Magomedova Sh. M. Diagnostika i klassifikatsiya prolapsa mitral'nogo klapana u detey i podrostkov. Kardiologiya 2011 ; 3: 63-67.

3. Butolin E.G., Sharaev P.N., Danilov G.E. Izmenenie soderzhanieya razlichnykh fraktsiy kollagena pri elektricheskoy stimulyatsii i elektrokoagulyatsii mindalevidnogo kompleksa mozga krolikov. Voprosy meditsinskoy khimii 1982; 28(5): 78-80.

4. Bukharin O.V., Chepal'chenko O.E., Valyshev A.V., Elagina M.M., Perunova N.B., Mikhaylova E.A., Fomicheva S.V. Mikroflora tolstogo kishechnika u patsientov s displaziey soedinitel'noy tkani. Zh. Mikrobiol. Epidemiol. Immunobiol. 2003;(3):62–66.

5. Gnusaev S.F. Belozerov Yu.M. Rabochaya klassifikatsiya malikh anomaliy razvitiya sertsa i ikh klinicheskoe znachenie u detey. Ul'trazvukovaya i funktsional'naya diagnostika 2002; 2: 175-176.

6. Gromova O.A. Molekulyarnye mekhanizmy vozdeystviya magniya na displaziyu soedinitel'noy tkani. Dislpaziya soedinitel'ny tkani 2008; 1 :23-32.

7. Gromova O.A. Magniy i piridoksin. Osnovy znaniy. ProtoTip 2006: 234.

8. Domnitskaya T.M. Prizhiznennaya diagnostika i klinicheskoe znachenie anomal'no raspolozhennykh khord u vzroslykh i deitey. Terapevticheskiy arkhiv 1997; 11: 60-67.

9. Zakharyan A.L., Zakharyan E.A. Tyazhest' varikoznoy bolezni ven nizhnikh konechnostey pri razlichnykh stepenyakh displazii soedinitel'noy tkani. Klin. Khir. 2005;(8):42–44.

10. Zemtsovskiy E.V. Soedinitel'notkannye displazii serdtsa. – SPb: TOO “Polineks-Nord_vest” 2000: 115

11. Zemtsovskiy E.V. Displasticheskie fenotipy. Displasticheskoe serdtse. - SPb.: “Ol'ga” 2007: 80.

12. Zemtsovskiy E.V. Nedifferentsirovannye displazii soedinitel'noy tkani. Sostoyanie i perspektivy razvitiya predstavleniy o nasledstvennykh rasstroystvakh soedinitel'noy tkani. Dislpaziya soedinitel'noy tkani 2008; 1: 5-9.

13. Kalinkina O.M. Priznaki displazii soedinitel'noy tkani v predpolagaemoy ishemicheskoy bolezni serdtsa. Kardiologiya 1988; 28(9):52–57.

14. Kommisarenko V.P., Minchenko A.G., Tron'ko N.D., Molekulyarnye mekhanizmy deystviya steroidnykh gormonov. Kiev. Zdorov'ye; 1986.

15. Martynov A.I. Stepura O.V., Ostroumova O.D. Markery displazii soediitel'noy tkani u bol'nykh s idipoaticheskim prolabirovaniem atriventrikulyarnykh klapanov i anomal'no raspolozhennymi khordami. Terapevticheskiy arkhiv 1996; 68(2): 40-43.

16. Makolkin V.I., Podzolkov V.I., Rodionov A.V., Sheyanov M.V., Samoylenko V.V., Napalkov D.A. Raznoobrazie klinicheskikh simptomov displazii soedinitel'noy tkani. Ter. Arkhiv 2004; 76(11):77–80.

17. Moshchich O. P., Mozgova Yu. A., Smіyan O.І.Porushennya sertsevoї dіyal'nostі u dіtey, khvorikh na khronіchniy tonzilіt ta shlyakhi їkh korektsії. Zbіrnik naukovikh prats' spіvrobіtnikіv NMAPO іmenі P. L. Shupika. Kiїv, 2014; 23 (1): 234 - 242

18. Nechaeva G.I., Druk I.V., Tikhonova O.V. Terapiya preparatami magniya pri pervichnom prolapse mitral'nogo klapana. Lechashchiy vrach 2007; 6: 2–7.

19. Ostroumova O.D., Stepura O.B., Mel'nik O.O.Prolaps mitral'nogo klapana – norma ili patologiya? Russkiy meditsinskiy zhurnal 2002; 28: 1314-1317.

20. Smol'nova і .Yu., Buyanova S.N., Savel'yev C.B. Fenotip i ches kiy simptomokompleksdisplazii soedi¬nitel'noy tkani u zhenshchin N Klinicheskaya meditsina 2003; 8: 42-48.

21. Nechaeva G.I. Variabel'nost' serdechnogo ritma u patsientov molodogo vozrasta s displaziey soedinitel'noy tkani. Displaziya soedinit. tkani 2008; 1: 10–13.

22. Storozhakov G.I. Gendlin G.E.Blokhina I.G. i dr. Lozhnye khordy: raspolozhenie v polosti levogo zheludochka i klinicheskaya znachimost'. Vizualizatsiya v klinike 1993; 2: 9-12.

23. Spirichev V.B. Rol' vitaminov i mineral'nykh veshchestv v osteogeneze i profilaktike osteopenii u detey. Voprosy detskoy dietologii 2003; 1(1): 40–49.

24. Surkina I.D., Gurevich K.G., Mel'nik O.O. i dr. Snizhenie sposobnosti limfotsitov krovi produtsirovat' interferon-g u bol'nykh s idiopaticheskim prolabirovaniem mitral'nogo klapana. Ter. arkhiv 2005; 9: 74-76.

25. Ter-Gastyan A.A., Galstyan A.A., Potapenko і F. Ano¬mal'no raspolozhennaya khorda i prolaps mitral'nogo klapana u detey i podrostkov. Ukr. revmatol, zhurnap 2001; 2(4): 58-62.

26. Torshin I.Yu., Gromova O.A. Displaziya soedinitel'noy tkani, kletochnaya biologiya i molekulyarnye mekhanizmy vozdeystviya magniya. Ros med zhurn 2008; 16; 4: 230-238

27. Filipenko P.S., Malookaya Yu.S. Rol' displazii soedinitel'noy tkani v formirovanii prolapsa mitral'nogo klapana. Klin. Med 2006;84(12):13–19.

28. Tsukanov Yu.T., Tsukanov A.Yu.. Varikoz nizhnikh konechnostey kak rezul'tat displazii soedinitel'noy tkani. Angiol. Sosud. Khir. 2004; 10(2):84–89.

29. Shilyaev R.R.. Shal'nova S.N. Dislpaziya soedinitel'noy tkani i ee svyaz' s patologiey u detey i vzroslykh. Voprosy sovremennoy pediatrii 2003; 5(2): 61-67.

30. Alberts B., Johnson A., Lewis J., Raff M., Roberts R., Walter P. Molecular Biology of the Cell, 4th edition, Garland Science, 2002, ISBN 0815340729.

31. Ahvazi B, Boeshans KM, Rastinejad F. The emerging structural understanding of transglutaminase 3. J Struct Biol. 2004;147(2):200–207.

32. Ahvazi B, Boeshans KM, Idler W, Baxa U, Steinert PM. Roles of calcium ions in the activation and activity of the transglutaminase 3 enzyme. J Biol Chem. 2003; 278(26): 23834–41 .

33. Cardy CM, Handford PA. Metal ion dependency of microfibrils supports a rod–like conformation for fibrillin–1 calcium–binding epidermal growth factor–like domains. J Mol Biol. 1998;276(5):855–860.

34. Cauwe B., Van den Steen P.E., Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol. 2007;42(3):113–185.

35. Clarke AW, Weiss AS. Microfibril–associated glycoprotein–1 binding to tropoelastin: multiple binding sites and the role of divalent cations. Eur J Biochem. 2004;271(14):3085–3090.

36. Cole W.G. Collagen genes: mutations affecting collagen structure and wxpression. Prog. Nucleic. Acid. Res. Mo. Biol. 1994; 47: 29-80.

37. Chubanov V., Waldegger S., Mederos y Schnitzler M., Vitzthum H., Sassen M.C., Seyberth H.W., Konrad M., Gudermann T. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc Natl Acad Sci U S A. 2004;101(9):2894–9.

38. Gakkard l.D. Baker S.M., McLellan R.K. Magnesium deficiency in the pathogenesis of mitral valve prolapsed. Magnesium 1986; 5 (3-4): 165-74.

39. Guo H, Lee JD, Uzui H, Yue H, Wang J, Toyoda K, Geshi T, Ueda T. Effects of folic acid and magnesium on the production of homocysteine–induced extracellular matrix metalloproteinase–2 in cultured rat vascular smooth muscle cells. Circ J. 2006;70(1):141–146.

40. Henrotte JG. The variability of human red blood cell magnesium level according to HLA groups. Tissue Antigens. 1980;15(5):419–430.

41. Kachru RB, Telischi M, Cruz JB, Patel R, Towne WD. The HLA antigens and ABO blood groups in an American Black population with mitral valve prolapse. Tissue Antigens. 1979;14(3):256–260.

42. Laurentaci G, Lomuto M, Favoino B. Immunogenetic analysis of association between HLA antigens and psoriasis vulgaris: population and family studies. Dermatologica. 1982;165(6):591–600.

43. Ludwig H, Mayr W. Genetic aspects of susceptibility to multiple myeloma. Blood. 1982;59(6):1286–1291.

44. Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci. 2006;11:1696–1701.

45. Mehra NK, Ahuja GK, Taneja V, Vaidya MC. HLA antigens and myasthenia gravis in north India. J Neurol Neurosurg Psychiatry. 1983;46(4):361–364.

46. Mio K, Carrette O, Maibach HI, Stern R. Evidence that the serum inhibitor of hyaluronidase may be a member of the inter–alpha–inhibitor family. J Biol Chem. 2000;275(42):32413–32421.

47. Pages N, Gogly B, Godeau G, Igondjo–Tchen S, Maurois P, Durlach J, Bac P. Structural alterations of the vascular wall in magnesium–deficient mice. A possible role of gelatinases A (MMP–2) and B (MMP–9). Magnes Res. 2003;16(1):43–48.

48. Rabaud M, Lefebvre F, Graves PV, Desgranges C, Bricaud H. Magnesium enhances human pancreatic elastase digestion of 125I–labeled elastin. Experientia. 1985;41(5):628–631.

49. Torshin I.Yu. Bioinformatics in the post–genomic era: physiology and medicine. Nova Biomedical Books, NY, USA (2007), ISBN: 1600217524, pp35–67.

50. Saarela T., Risteli J., Kauppila A., Loivisto M., Effect of short-term antyenatal dexamethasone administration on type I collagen synthesis and degradation in preterm infants at birth. Acta Paediatr. 2001; 90(8): 921-925.

51. Shingleton W.D., Hodges D.J., Brick P., Cawston T.E. Collagenase: a key enzyme in collagen turnover. Biochem Cell Biol. 1996;74(6):759–775.

52. Schlingmann K.P., Weber S., Peters M., Niemann Nejsum L., Vitzthum H., Klingel K., Kratz M., Haddad E., Ristoff E., Dinour D., Syrrou M., Nielsen S., Sassen M., Waldegger S., Seyberth H.W., Konrad M. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet. 2002;31(2):166–70.

53. Ueshima K, Shibata M, Suzuki T, Endo S, Hiramori K. Extracellular matrix disturbances in acute myocardial infarction: relation between disease severity and matrix metalloproteinase–1, and effects of magnesium pretreatment on reperfusion injury. Magnes Res. 2003;16(2):120–126.

54. van Venrooij WJ. Autoantibodies against small nuclear ribonucleoprotein components. J Rheumatol Suppl. 1987;14 Suppl 1:78–82.

55. Walker WG, Hillis WD, Hillis A. Hepatitis B infection in patients with end stage renal disease: some characteristics and consequences. Trans Am Clin Climatol Assoc. 1980;92:142–151.

56. Wang Z., Hu S.Y., Lei D.L., Song W.X. Effect of chronic stress on PKA and P–CREB expression in hippocampus of rats and the antagonism of antidepressors Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006;31(5):767–771.

57. Zeana CD. Recent data on mitral valve prolapse and magnesium deficit. Magnes Res. 1988;1(3–4):203–211.